December 16, 2017 12:46 PM ET

Biotechnology

Company Overview of Vir Biotechnology, Inc.

Key Executives for Vir Biotechnology, Inc.

NameBoard RelationshipsTitleAge
George A. Scangos Ph.D.144 RelationshipsCEO & Director69
Lawrence Corey M.D.31 RelationshipsCo-Founder and Scientific Advisor--
Klaus Frueh Ph.D.8 RelationshipsCo-Founder and Director--
Robert T. Nelsen 227 RelationshipsCo-Founder and Director55
Louis J. Picker M.D.9 RelationshipsCo-Founder and Scientific Advisor--
View More Key Executives

Vir Biotechnology, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Vicki L. Sato Ph.D. 93 RelationshipsGinger.io, Inc.68
George A. Scangos Ph.D. 144 RelationshipsVir Biotechnology, Inc.69
Klaus Frueh Ph.D. 8 RelationshipsVir Biotechnology, Inc.--
Robert T. Nelsen 227 RelationshipsJuno Therapeutics, Inc.55
Kristina Burow 106 RelationshipsArch Venture Partners, L.P.44
View All Board Members

Vir Biotechnology, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
384.5K
Bonus
235.5K
Total Short Term Compensation
479.2K
Total Value of Options
18.0M
Compensation as of Fiscal Year
Vir Biotechnology, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Sunesis Pharmaceuticals, Inc. Announces Management Changes
December 15, 2017 10:09 PM ET
ContraFect Corporation Announces Executive Changes
December 15, 2017 9:52 PM ET
Biotoscana Investments S.A. Hires Ivan French as Executive Vice President of Research and Development
December 15, 2017 9:36 PM ET
Minerva Neurosciences, Inc. Announces Management Changes
December 15, 2017 9:31 PM ET
Applied Genetic Technologies Corporation Announces Resignation of R. Guyer from the Board
December 15, 2017 9:16 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Vir Biotechnology, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.